-
Zevaquenabant (S-MRI-1867, INV-101, or MRI-1867) is an
investigational small-molecule drug,
discovered by Dr
George Kunos, Dr
Resat Cinar, and Dr Malliga...
-
Surinabant (SR147778)
Taranabant (MK-0364) TC-C 14G TM-38837
VCHSR Voacamine Zevaquenabant See also:
Cannabinoid receptor modulators (cannabinoids by pharmacology)...
-
Surinabant (SR147778)
Taranabant (MK-0364) TC-C 14G TM-38837
VCHSR Voacamine Zevaquenabant See also:
Cannabinoid receptor modulators (cannabinoids by pharmacology)...
-
anxiety and
sleep disturbances.
Suicidal ideations were not reported.
Zevaquenabant Liu, Ziyi; Iyer,
Malliga R.; Godlewski, Grzegorz; Jourdan, Tony; Liu...
- AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545
Cannabidiol Cannabigerol Drinabant Falcarinol (carotatoxin)...
- AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545
Cannabidiol Cannabigerol Drinabant Falcarinol (carotatoxin)...
-
Surinabant (SR147778)
Taranabant (MK-0364) TC-C 14G TM-38837
VCHSR Voacamine Zevaquenabant See also:
Cannabinoid receptor modulators (cannabinoids by pharmacology)...
- AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545
Cannabidiol Cannabigerol Drinabant Falcarinol (carotatoxin)...
-
Surinabant (SR147778)
Taranabant (MK-0364) TC-C 14G TM-38837
VCHSR Voacamine Zevaquenabant See also:
Cannabinoid receptor modulators (cannabinoids by pharmacology)...
-
Virodhamine (Endogenous CB1
antagonist and CB2 agonist)
Rimonabant Taranabant Zevaquenabant Monlunabant INV-202
Lipoxin A4 – endogenous, PAM ZCZ-011 – PAM Pregnenolone...
